Breaking Science in Breast Cancer with Hope Rugo – ESMO

ESMO shared a post on LinkedIn:

“For ESMO members: Breaking Science in Breast Cancer.

Hope Rugo shares insights on her presentation about capivasertib and fulvestrant for AI-resistant HR+/HER2– ABC.

Watch this video and others from this series on OncologyPRO now.”

Source: ESMO/LinkedIn

The European Society for Medical Oncology (ESMO) represents over 35,000 oncology professionals across 172 countries and is a key resource for oncology education and information.

ESMO’s primary mission is to enhance the quality of cancer care, spanning prevention, diagnosis, palliative care, and patient follow-up.

It focuses on educating doctors, cancer patients, and the general public about best practices and the latest advancements in oncology, and advocates for equal access to optimal cancer care for all patients.